🕵️ CVRX, Inc. ($CVRX)
SEC insider & ownership activity, last 12 months · CIK 1235912 · every row links its SEC filing
Over the last 12 months insiders sold $988K against $300K of open-market buying. Johnson & Johnson sold $861K (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $300K (2 lots) · 6 sellers, $988K (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Johnson & Johnson | 0 | – | 8 | $861K | Nov 26, 2025 |
| Mudit K. Jain | 2 | $300K | 0 | – | Feb 20, 2026 |
| Hykes Kevin | 0 | – | 1 | $61K | Mar 2, 2026 |
| John Robert Allen | 0 | – | 1 | $31K | Mar 2, 2026 |
| Oasheim Jared | 0 | – | 1 | $14K | Mar 2, 2026 |
| Verrastro Paul | 0 | – | 1 | $10K | Mar 2, 2026 |
| Philip B. Adamson | 0 | – | 1 | $10K | Mar 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Johnson & Johnson | 15.4% | 13G | Jan 12, 2026 | filing ↗ | |
| Johnson & Johnson Innovation - JJDC, Inc. | 15.4% | 13G | Jan 12, 2026 | filing ↗ | |
| Scott D. Sandell | 7.8% | 13D | Feb 18, 2025 | filing ↗ | |
| Anthony A. Florence, JR. | 7.8% | 13D | Feb 18, 2025 | filing ↗ | |
| Mohamad H. Makhzoumi | 7.8% | 13D | Feb 18, 2025 | filing ↗ | |
| New Enterprise Associates 10, Limited Partnership | 7.8% | 13D | Feb 18, 2025 | filing ↗ | |
| NEA Partners 10, Limited Partnership | 7.8% | 13D | Feb 18, 2025 | filing ↗ | |
| Kirk Nielsen | 7.2% | 13G | Feb 6, 2025 | filing ↗ | |
| Vensana Capital I GP, LLC | 7.1% | 13G | Feb 6, 2025 | filing ↗ | |
| Vensana Capital I, L.P. | 7.1% | 13G | Feb 6, 2025 | filing ↗ | |
| Peter Justin Klein | 7.1% | 13G | Feb 6, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Apr 13, 2026 | filing ↗ |
| Other events (8.01) | Apr 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 9, 2026 | filing ↗ |
| Earnings (2.02) | Jan 9, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 9, 2026 | filing ↗ |
| Other events (8.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Earnings (2.02) | Aug 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2025 | filing ↗ |